In this week's episode, Dr. Lynn Kirkpatrick, CEO of Encyse Biosciences, discusses her journey from academia to entrepreneurship, focusing on innovative solutions for opioid delivery. She highlights the unique approach of her company in developing a safer opioid alternative, the challenges faced in the pharmaceutical industry, and her vision for improving pain management for patients.Ensysce Biosciences Website: <a rel="noopener noreferrer nofollow" href="https://ensysce.com/" target="_blank">https://ensysce.com/</a>Nano Cap Podcast Website: <a rel="noopener noreferrer nofollow" href="https://www.nanocappod.com/" target="_blank">https://www.nanocappod.com/</a>DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

Virtuix - $VTIX - Ep:054 - Nano Cap Podcast

On the Nano Cap Podcast, we dive into the unique world of publicly traded companies with a market capitalization under $50 million – the nano caps. These are not just numbers on a stock ticker; they are stories of ambition, struggle, and triumph.

Each episode, I'll sit down with the leaders and visionaries behind these companies. We’ll uncover the challenges they face, the innovations they bring, and the strategies that drive them forward in a competitive market.